Join our CEO Lisa Deschamps at LSEG (London Stock Exchange Group)'s The Future of Healthcare Investment Forum for a roundtable discussion on Neuropsychology and Neurodegeneration and emerging approaches to treatment, moderated by Kevin Grogan, Managing Editor Europe, Scrip Citeline Commercial. View the full agenda: herehttps://lnkd.in/giaWVhEn #frontotemporaldementia #aviadobio
AviadoBio’s Post
More Relevant Posts
-
ICYMI: Maneesh Jain and GV (Google Ventures)'s Cathy Friedman discuss the momentum surrounding #PregnancyHealth and #WomensHealth and why 2024 will be a banner year for both. Check out the conversation below 👇 and let us know your thoughts!
New perspectives on women’s health are emerging in 2024. GV’s Executive Venture Partner Cathy Friedman sat down with Mirvie’s co-founder and CEO Maneesh Jain to discuss closing the gap in biomedical innovation — https://bit.ly/3NX3Jx2
To view or add a comment, sign in
-
-
Great discussion here with Cathy Friedman and Maneesh Jain!
New perspectives on women’s health are emerging in 2024. GV’s Executive Venture Partner Cathy Friedman sat down with Mirvie’s co-founder and CEO Maneesh Jain to discuss closing the gap in biomedical innovation — https://bit.ly/3NX3Jx2
To view or add a comment, sign in
-
-
Our transformation today reflects where we’ve come from, and where we’re heading together. Accelerating science. Transforming health. Expanding human potential. This is Revvity. http://ms.spr.ly/6041i8gM5
To view or add a comment, sign in
-
Did you know that Integrated Medical Capabilities and all Envision solutions can be complemented with Behavioral Science? By harnessing the power of behavioral science, we can address a wide array of medical and healthcare communication challenges to improve health outcomes. Our flagship, proprietary Feel-Think-DoTM Insight model allows us to identify behavioral insights that we use to develop strategy and implementation plans that drive meaningful change. #EnvisionPharma #LifeSciences #BehavioralScience
To view or add a comment, sign in
-
Happy New Year!! If you are going to be in JPM, please meet me and our Chief Scientific Officer, Dr. Alan Kozikowski and let’s talk about PurMinds NeuroPharma’s pursuit of therapeutics for neurological disorders. #neuroscience #smallmolecules #psychedelicscience #neurodegenerativediseases
Are you attending the 42nd Annual J.P. Morgan Healthcare Meeting, January 08-11, 2024, in San Francisco? Join CEO Janet Qi and our chief scientists at this premier healthcare investment symposium, connecting with industry leaders and innovators. Ready to explore future collaborations? Book a meeting with PurMinds by reaching out to ir@hlthcommunications.com. Let's shape the future of healthcare together! #JPMHC #HealthcareInnovation #Neuro
To view or add a comment, sign in
-
-
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐨𝐟 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧'𝐬 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭, 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲𝐢𝐧𝐠 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐭𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐟𝐨𝐫 𝐞𝐧𝐡𝐚𝐧𝐜𝐞𝐝 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐚𝐫𝐞 𝐚𝐧𝐝 𝐧𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬. Leverage our affordable market research and analysis services to explore future developments and opportunities in your business domain. Our #market research methodology is tailored to each industry, drawing on our agility, extensive experience, and market analysis expertise. We prioritize confidentiality and offer customized solutions. Using primary and secondary research, in-house verification, and industry-leading tools, we present findings in a format for easy evaluation. Get in touch for syndicated market research reports! #syndicatemarketreport #syndicateresearchreport #syndicatetechnologyreport #samplemarketreport #sampletechnologyreport #marketreport #technologyreport #technologyanalysis
To view or add a comment, sign in
-
-
In a recent interview with Life Sciences Review, Jay Scherer, Discovery’s Chief Operating Officer, shared how our Science at Your Service philosophy enables our clients to ignite breakthroughs in precision medicine. Read the article: https://lnkd.in/gSVvctJR Discovery is deeply committed to helping researchers worldwide advance therapies and improve patient outcomes. During his interview, Jay mentions that, “our team members and customers often share personal incidents of health challenges. These stories remind us that there is a patient with hope behind every sample we provide.” We believe each biospecimen sample and every service we provide could hold the key to the next significant medical breakthrough. #PrecisionMedicine #Biospecimens #DrugDevelopment
To view or add a comment, sign in
-
-
Have a look at this brief introduction to Parexel's Early Health Economic Model Approach: ICER’s cost-effectiveness reports are playing an increasingly significant role in payer coverage decisions. Early economic models can be invaluable in providing decision-makers with early insights into key drivers, evidence gaps, and the potential economically justifiable price. Our Access Consulting team is always available for a conversation to help you optimize your engagement with ICER: AccessCustomerStrategy@parexel.com
Early Economic Models for ICER | Access Consulting | Parexel
share.parexel.social
To view or add a comment, sign in
-
“Our hope is that with a validated device for use in narcolepsy, we can contribute to limiting the burden of traveling to a sleep center. Beyond the clinical trial setting, a validated Digital Health Tool could help to improve the diagnostic journey by allowing for a timely differential diagnosis for people living with narcolepsy.” So exciting to see this initiative to pair the development of a therapeutic innovation with digital innovation to add more value for patients living with narcolepsy.
In a Q&A with Clinical Leader, Elena Koundourakis, head of the Orexin franchise development and neuroscience portfolio strategy, explains why Takeda is exploring the use of digital health tools with Beacon Biosignals to support future clinical development and diagnosis of narcolepsy. Read more here: https://lnkd.in/eVQb-Fer #WhereScienceis #WhereScienceIsDigital
Takeda Chooses Wearable To Improve Patient Experience & Data In Sleep Study
To view or add a comment, sign in
-
The 2024 #STATUSList is here: Introducing the ultimate list of 50 leaders shaping the future of health and life sciences! Check out this years highlighted change makers. https://lnkd.in/eDb7Ub_j
2024 STATUS List
statnews.com
To view or add a comment, sign in
Managing Editor Europe, Commercial at Scrip
2moVery much looking forward to this